It also functions as an antioxidant and anti-inflammatory agent
Monday Poster Session Category: Small Intestine P4045 - Comparative Risk of Small Intestinal Bacterial Overgrowth (SIBO) Among Patients Using GLP-1 Receptor Agonists: A Real-World Analysis Using TriNetX Monday, October 27, 2025 10:30 AM - 4:00 PM PDT Location: Exhibit Hall Has Audio Presenting Author(s) Lina AlQirem, MD 1 , Suria Devarapalli, DO 1 , Adalberto Guzman, MD 2 , Murad Qirem, MD 3 , Meer A
Should I tell my pediatrician I am taking GLP-1 medication
Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in research subjects
When to Adjust Your Semaglutide Therapy at PlexusDx The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609) variants that relate to GLP-1 and related signaling pathways
Sarah Mitchell and Prof